Cardiovascular Systems, Inc. (CSII)
(Delayed Data from NSDQ)
$39.49 USD
+1.98 (5.28%)
Updated May 3, 2019 04:00 PM ET
After-Market: $39.52 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$39.49 USD
+1.98 (5.28%)
Updated May 3, 2019 04:00 PM ET
After-Market: $39.52 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
Hill-Rom (HRC) Q1 Earnings Meet, Revenues Lag Estimates
by Zacks Equity Research
Hill-Rom Holdings, Inc. (HRC) reported first-quarter fiscal 2017 adjusted earnings per share of 75 cents, up 10.3% from the year-ago quarter.
Cardiovascular Systems (CSII) Q2 Earnings Better Estimates
by Zacks Equity Research
Cardiovascular Systems, (CSII) reported earnings per share of 3 cents in second-quarter fiscal 2017, reflecting a massive improvement from the year-ago quarter's loss of 47 cents.
Mead Johnson (MJN) Misses Q4 Earnings, Sales; Guides '17
by Zacks Equity Research
Mead Johnson (MJN) reported fourth-quarter 2016 adjusted EPS of 78 cents, missing the Zacks Consensus Estimate of 83 cents by 6%.
Quest Diagnostics (DGX) Tops Q4 Earnings, Offers '17 View
by Zacks Equity Research
Quest Diagnostics' (DGX) fourth-quarter 2016 adjusted earnings per share (EPS) of $1.31 came in 4 cents ahead of the Zacks Consensus Estimate.
PetMed (PETS) Lags Q3 Earnings Estimates, Tops Revenues
by Zacks Equity Research
PetMed Express (PETS) announced earnings per share (EPS) of 24 cents for the third quarter of fiscal 2017.
New Strong Buy Stocks for January 26th
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Thursday
Abbott Labs (ABT) Tops Q4 Earnings Estimates, Sales In Line
by Zacks Equity Research
Abbott Laboratories (ABT) reported fourth-quarter 2016 earnings from continuing operations of 65 cents per share, a penny higher than the Zacks Consensus Estimate.
ResMed (RMD) Beats Earnings and Revenue Estimates in Q2
by Zacks Equity Research
ResMed Inc. (RMD) announced second-quarter fiscal 2017 adjusted earnings per share (EPS) of 73 cents, consistent with the prior-year quarter level.
Medical Product Stock Earnings on Jan 25: MCK, VAR & More
by Zacks Equity Research
Let's take a look at the major Medical Product stocks slated to release their earnings results on Jan 25.
New Strong Buy Stocks for January 23rd
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Monday
Quest Diagnostics (DGX) Launches HBV Quantitative Test
by Zacks Equity Research
Quest Diagnostics Inc. (DGX), a global provider of diagnostic information services, recently rolled out Hepatitis B Virus (HBV) Quantitative Test.
VWR Buys SEASTAR CHEMICALS to Boost Americas Division
by Zacks Equity Research
VWR Corporation (VWR) recently announced the acquisition of Canada-based SEASTAR CHEMICALS Inc.
Cardiovascular Systems (CSII): Q1 Solid, Net Losses Linger
by Zacks Equity Research
On Dec 27, we issued an updated research report on St. Paul, MN-based Cardiovascular Systems, Inc. (CSII).
4 Growth Stocks to Buy Amid Obamacare Repeal Talks
by Zacks Equity Research
Affordable Care Act (ACA) has been one of the most discussed topics during the 2016 U.S. presidential election. Even after a month, it has been contributing to the discord in the healthcare investment market.
Omnicell Unveils XT Series Automated Dispensing System
by Zacks Equity Research
Omnicell, Inc. (OMCL) recently introduced a new generation of medication and supply automation that is fully integrated with the company's Unity enterprise platform -- XT series.
Zacks.com featured highlights: Cisco Systems, Cardiovascular Systems, Five9, Generac Holdings and Nxstage Medical
by Zacks Equity Research
Zacks.com featured highlights: Cisco Systems, Cardiovascular Systems, Five9, Generac Holdings and Nxstage Medical
Top Stocks with Big Potential Catch-Up Moves
by Kevin Matras
Given the recent run-up in the market, here's a screen I've been using recently. Highlighted stocks include CSCO, CSII, FIVN, GNRC and NXTM.
New Strong Buy Stocks for November 4th
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Friday